Australia markets closed

MediciNova, Inc. (MNOV)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3100-0.0100 (-0.76%)
At close: 04:00PM EDT
1.3100 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 64.25M
Enterprise value 13.47M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)64.25
Price/book (mrq)1.03
Enterprise value/revenue 13.47
Enterprise value/EBITDA -1.36

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 3-37.32%
S&P500 52-week change 322.36%
52-week high 32.6600
52-week low 31.2600
50-day moving average 31.3980
200-day moving average 31.7946

Share statistics

Avg vol (3-month) 349.1k
Avg vol (10-day) 316.58k
Shares outstanding 549.05M
Implied shares outstanding 649.05M
Float 842.28M
% held by insiders 12.56%
% held by institutions 121.09%
Shares short (15 Apr 2024) 4246.99k
Short ratio (15 Apr 2024) 44.41
Short % of float (15 Apr 2024) 40.60%
Short % of shares outstanding (15 Apr 2024) 40.50%
Shares short (prior month 15 Mar 2024) 4326k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-990.03%

Management effectiveness

Return on assets (ttm)-8.81%
Return on equity (ttm)-12.93%

Income statement

Revenue (ttm)1M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -9.88M
Net income avi to common (ttm)-8.57M
Diluted EPS (ttm)-0.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)51M
Total cash per share (mrq)1.04
Total debt (mrq)626.59k
Total debt/equity (mrq)1.00%
Current ratio (mrq)15.61
Book value per share (mrq)1.27

Cash flow statement

Operating cash flow (ttm)-7.43M
Levered free cash flow (ttm)-5.12M